RecruitingNot ApplicableNCT06395935

Wecare Study in Gastric Cancer Survivors

A Multi-center, Prospective, Randomized Study to Evaluate the Usefulness of Applying the Chronic Side Effect Management Platform (Wecare) in Gastric Cancer Survivors


Sponsor

Gyeongsang National University Hospital

Enrollment

88 participants

Start Date

Apr 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The KOrean QUality of life in Stomach cancer patients Study group (KOQUSS) made a method (KOQUSS-40) for assessing appropriately the quality of life of gastric cancer patients who have undergone gastrectomy, and developed a digital platform (Wecare) based on KOQUSS-40. In this study, we propose a randomized controlled trial to compare quality of life after gastrectomy in patients with and without smartphone app support.


Eligibility

Min Age: 19 YearsMax Age: 75 Years

Inclusion Criteria1

  • Adult patient (19-75 years) who underwent radical gastrectomy

Exclusion Criteria1

  • Patients who were unable to undergo regular follow-up, lacked communication, or were deemed unsuitable to participate in this study by the researcher

Interventions

OTHERWecare (website)

support feedback of qutionaire \& supply educational contents


Locations(1)

Gyeongsang National University Hospital

Changwon, Gyeongsandnam-do, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06395935


Related Trials